Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Transplantation and Cellular Therapy
|
October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Blood Advances
|
August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Hemasphere
|
February 27, 2023
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis
Sjoerd J F Hermans, Jurjen Versluis, Myriam Labopin, et al.
Bone Marrow Transplantation
|
September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Bone Marrow Transplantation
|
September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Agnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, et al.
Bone Marrow Transplantation
|
January 26, 2022
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT
Giorgia Battipaglia, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Blood Advances
|
February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
Anna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2014
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Corrado Girmenia, Anna Maria Raiola, Alfonso Piciocchi, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Transplantation and Cellular Therapy
|
October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Blood Advances
|
August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Hemasphere
|
February 27, 2023
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis
Sjoerd J F Hermans, Jurjen Versluis, Myriam Labopin, et al.
Bone Marrow Transplantation
|
September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Bone Marrow Transplantation
|
September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Agnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, et al.
Bone Marrow Transplantation
|
January 26, 2022
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT
Giorgia Battipaglia, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Blood Advances
|
February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
Anna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2014
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Corrado Girmenia, Anna Maria Raiola, Alfonso Piciocchi, et al.
Page
of 9